Transcend Capital Advisors LLC Sells 414 Shares of Humana Inc. $HUM

Transcend Capital Advisors LLC cut its stake in shares of Humana Inc. (NYSE:HUM) by 31.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 916 shares of the insurance provider’s stock after selling 414 shares during the quarter. Transcend Capital Advisors LLC’s holdings in Humana were worth $224,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Cary Street Partners Investment Advisory LLC boosted its stake in Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after acquiring an additional 46 shares in the last quarter. Zions Bancorporation National Association UT bought a new position in Humana during the first quarter worth $37,000. CVA Family Office LLC boosted its stake in Humana by 63.4% during the second quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock worth $54,000 after acquiring an additional 85 shares in the last quarter. Ransom Advisory Ltd bought a new position in Humana during the first quarter worth $66,000. Finally, Transamerica Financial Advisors LLC boosted its stake in Humana by 1,027.6% during the first quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider’s stock worth $87,000 after acquiring an additional 298 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on HUM. Mizuho increased their target price on shares of Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Royal Bank Of Canada raised their price objective on shares of Humana from $283.00 to $322.00 and gave the company an “outperform” rating in a research note on Thursday, August 21st. Morgan Stanley dropped their price objective on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 31st. Wolfe Research raised their price objective on shares of Humana from $283.00 to $313.00 and gave the company an “outperform” rating in a research note on Monday, October 6th. Finally, The Goldman Sachs Group started coverage on shares of Humana in a research note on Tuesday, October 14th. They issued a “sell” rating and a $235.00 price objective on the stock. Eight analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $297.58.

Humana Stock Performance

Shares of HUM stock opened at $285.78 on Friday. The firm has a 50-day moving average of $281.78 and a 200-day moving average of $259.04. The company has a market cap of $34.37 billion, a P/E ratio of 21.93, a P/E/G ratio of 1.71 and a beta of 0.42. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. Humana Inc. has a one year low of $206.87 and a one year high of $315.35.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to analysts’ expectations of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.96 EPS. Equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, December 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. Humana’s dividend payout ratio is currently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.